Table 3.
Cytokines |
Test Applied | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IL-6 | IL-10 | bFGF | GM-CSF | IP-10 | MCP-1 | MIP-1α | RANTES | VEGF | MCP-3 | MIF | TRAIL | ICAM-1 | VCAM-1 | ||
Ciliary body ingrowth | 0.04 | 0.60 | 0.13 | 0.05 | 0.81 | 0.26 | 0.08 | 0.05 | 0.21 | 0.30 | 0.04 | 0.22 | 0.16 | 0.11 | t-Test |
Largest basal diameter | 0.13 | 0.39 | 0.31 | 0.06 | 0.44 | 0.43 | 0.32 | 0.03 | 0.91 | 0.91 | 0.40 | 0.84 | 0.78 | 0.86 | Spearman's correlation |
Prominence | 0.67 | 0.63 | 0.38 | 0.55 | 0.94 | 0.43 | 0.74 | 0.81 | 0.02 | 0.58 | 0.26 | 0.73 | 0.74 | 0.83 | Spearman's correlation |
Tumor size pTNM (7th edition) | 0.71 | 0.40 | 0.10 | 0.98 | 0.48 | 0.54 | 0.88 | 0.50 | 0.77 | 0.99 | 0.31 | 0.92 | 0.99 | 0.51 | ANOVA |
Presence of epithelioid cell type | 0.77 | 0.47 | 0.89 | 0.28 | 0.47 | 0.91 | 0.69 | 0.96 | 0.80 | 0.02 | 0.86 | 0.22 | 0.36 | 0.96 | t-Test |
Microvascular density | 0.21 | 0.69 | 0.42 | 0.82 | 0.42 | 0.33 | 0.15 | 0.08 | 0.81 | 0.08 | 0.79 | 0.39 | 0.33 | 0.70 | ANOVA |
Presence of monosomy 3 | 0.48 | 0.40 | 0.63 | 0.52 | 0.46 | 0.50 | 0.08 | 0.31 | 0.77 | 0.13 | 0.94 | 0.22 | 0.11 | 0.30 | t-Test |
HLA class I with HC10 staining | 0.72 | 0.40 | 0.13 | 0.97 | 0.08 | 0.93 | 0.19 | 0.64 | 0.56 | 0.59 | 0.20 | 0.18 | 0.15 | 0.59 | Spearman's correlation |
HLA class I with HCA2 staining | 0.91 | 0.39 | 0.74 | 0.78 | 0.56 | 0.39 | 0.85 | 0.60 | 0.15 | 1.00 | 0.49 | 0.13 | 0.12 | 0.08 | Spearman's correlation |
HLA Class II with HLA-DR staining | 0.26 | 0.97 | 0.23 | 0.03 | 0.80 | 0.55 | 0.46 | 0.11 | 0.75 | 0.03 | 0.95 | 0.01 | 0.27 | 0.78 | Spearman's correlation |
Survival analysis | 0.21 | 0.92 | 0.47 | 0.99 | 0.16 | 0.30 | 0.40 | 0.06 | 0.40 | 0.71 | 0.31 | 0.65 | 0.39 | 0.94 | Cox regression |
P-values shown in bold indicate a significant correlation.